Development of Severe Pemphigus Vulgaris Following ChAdOx1 nCoV-19 Vaccination and Review of Literature.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of cosmetic dermatology"
DOI: 10.1111/jocd.14945
Abstract: Vaccines are indeed a boon for tackling the present COVID-19 pandemic. In India, ChAdOx1 nCoV-19 (Covishield) is the most commonly used vaccine in the government vaccination programme for adults more than 18 years of age.… read more here.
Keywords: chadox1 ncov; vaccination; pemphigus vulgaris; severe pemphigus ... See more keywords